CS Paper Radar

Large language models as oncology world models

Julien Vibert, Jakob Nikolas Kather

cs.LG cs.AIcs.CL ·submitted 2026-11-13 22:49 UTC · v1
code/data

Abstract

Large language models (LLMs) can synthesize cancer patient cases, but their internal representation of oncology, or world model, has not been explored systematically. By only specifying tumor type, we show that LLMs tend to generate similar patients per cancer, with on average 81.0% to 93.2% of a cancer's patients sharing the most frequent value of each baseline feature. By systematically varying patient features in 12 clinical scenarios, we show that they follow biomarker and treatment logic in 29 of 36 model-scenario assessments, against 1 of 12 when previous treatment or frailty matters. Continuing real patient trajectories, an LLM predicted 89.9% 12-month survival, and 79.2% with similar patients as examples, against 72.2% observed. To represent these trajectories, we developed the Clinical State Space, a dynamic representation framework that we also applied to real patients. Despite the limits we show, improved world models may support digital twins, which our framework can evaluate.

Comment
63 pages (main text 35, Supplementary Information 28), 6 figures, 9 Extended Data figures. Code: https://github.com/julienvibert/llm-oncology-world-models. Data: https://doi.org/10.5281/zenodo.24137512

Closest papers

Nearest neighbours by meaning across the whole index.

LifeLong Digital Twin: A Unified Modeling Paradigm and Agent Harness for Event-Driven Lifelong Health State Trajectories

cs.AI q-bio.QM ·2026-10-04 ·Jin Jiang, Sean Yates, Jasper Chong, Raymond Brooks, Alex Lawson +2 more
similarity 0.70
Abstract · 15 pages, 5 figures, 2 tables. Technical report

Human health is a continuous, dynamic trajectory shaped by the cumulative interplay of biological processes, clinical events, behaviors and environmental exposures across the life course. Unifying the full breadth of lifelong health information, including longitudinal records, genetic variation, molecular profiles and environmental histories, is essential for whole-person modeling and remains a major challenge. We introduce LifeLong Digital Twin, a unified, event-driven modeling paradigm that organizes Life Events into daily Health States and accumulates them into Lifelong Health Context. An accompanying Agent Harness incorporates multimodal evidence beyond the language model's textual context. We evaluate four language models across 25 disease endpoints on three tasks: Disease Trajectory Forecasting, Disease Risk Ranking and Multi-horizon Disease Prediction. The approach yields marked gains over the reference condition: model-averaged F1 increases by 22.0% for disease identification in trajectory forecasting and 18.3% for five-year disease outcomes; thyroid-disease F1 reaches 0.669. The framework provides a foundation for whole-person digital twins and research on personalized lifelong disease prevention.

0.20

OncoNoteBERT: A Foundation Representation Model for Natural Language Processing of Real-World Outpatient Oncology Notes

cs.CL cs.AIcs.LGq-bio.QM ·2026-10-02 ·Wuraola Oyewusi, Eliana Vasquez Osorio, Goran Nenadic, Gareth Price
published similarity 0.66
Abstract · Accepted at the AI at Scale for Clinical Impact (ASCI): Cancer Pathology Foundation Models Workshop at NeurIPS 2026

Real-world outpatient oncology notes contain specialised terminology, tumour staging expressions, treatment names, toxicity descriptions, and institution-specific de-identification markers that may not be represented efficiently by general biomedical or adjacent clinical language models. We developed and evaluated oncology-specific BERT-style encoders using a governed UK outpatient oncology corpus comprising 290,026 notes from 21,564 patients treated for lung and head-and-neck cancer. We compared RadBERT and PathologyBERT with two local strategies: OncoNote-RadBERT, produced by continued masked language model pretraining, and OncoNoteBERT, trained from scratch with an oncology WordPiece tokenizer. Models were evaluated using masked language modelling loss and perplexity on the validation set, tokenizer fragmentation metrics, clinical term tokenisation, masked-token probes, and exploratory representation analysis. Both external encoders fit the oncology corpus poorly in zero-shot evaluation (perplexity 113.04 for RadBERT; 2035.03 for PathologyBERT), while continued pretraining produced the strongest fit (2.10 for OncoNote-RadBERT). OncoNoteBERT achieved perplexity 2.83 but produced the most efficient tokenisation, with lower subword fertility and shorter normalised sequence length. It also returned a clinically acceptable prediction for 12 of 13 masked-token probes, compared with 7 of 13 for OncoNote-RadBERT. This divergence between corpus-level fit and masked-token performance was partly attributable to tokenizer fragmentation rather than learned semantics alone. Both locally developed models represented the institutional placeholder as a single learnable token. These findings show that continued adaptation and bespoke tokenisation provide complementary benefits, and that representation-layer design matters before adjacent-domain encoders are applied to oncology NLP.

0.30

A Multimodal Foundation Model for Longitudinal Patient Representation and Scalable Insight Generation in Oncology

cs.LG ·2026-08-25 ·Eugene Vorontsov, Yi Kan Wang, Alican Bozkurt, Adam Casson, Ludmila Tydlitatova +11 more
similarity 0.66
Abstract

Precision oncology necessitates a longitudinal model of patient state that captures cancer evolution and treatment over time, integrating multimodal observations. We introduce the oFM, a foundation model developed on a real-world oncology cohort of 1.67 million cancer patients that integrates clinical trajectories with DNA, RNA, and H&E pathology. Patient-level partitions were reserved for training, validation, and testing, with over one million patients used for training. The oFM encodes daily clinical and molecular episodes and, along with pathology images, integrates them over time to produce a patient state embedding. We evaluate frozen oFM embeddings against expert-curated clinical and molecular baseline features. In prognostic benchmarks, the oFM improved AUC for treatment response, progression-free survival, and overall survival (0.774 vs. 0.563 for overall survival). Across 11 comparative-treatment cohorts, the oFM embeddings achieved a three-fold higher pooled and scale-normalized treatment-benefit AUTOC than baseline features with improved benefit ranking in 9 of 11 cohorts, and provided stronger prognostic discrimination within both treatment arms. We also evaluated a mechanism discovery framework that interprets downstream models built on oFM embeddings by linking their predicted outcomes to clinically and biologically grounded mechanisms through an evidence-grounded temporal graph, enabling evaluation in clinical and drug-development applications.

0.09

Patient-specific rubric-based evaluation of large language models across longitudinal cancer care

cs.AI ·2026-10-26 ·Wei-Wei Zhang, Pengkai Wang, Yan Li, Zhijie Sang, Guan-Qun Zhou +11 more
benchmark similarity 0.64
Abstract

Large language models (LLMs) show promise in specialty medicine, yet existing evaluations largely focus on isolated clinical encounters rather than tracking how clinical responsibilities evolve across a longitudinal care pathway. Here we introduce NPC-RubricBench, a phase-aware benchmark for evaluating multistage clinical reasoning across the cancer care continuum, using nasopharyngeal carcinoma as a defined disease context. Curated from longitudinal records of 405 patients across two cancer centers, the benchmark comprises 941 patient-phase units across six sequential care phases and 17,688 patient-specific atomic criteria spanning five evaluation dimensions, with each assessment strictly restricted to decision-time clinical evidence. Evaluating 30 general-purpose and medical LLMs revealed that strong diagnostic performance does not carry over to downstream care. We evaluated 30 general-purpose and medical LLMs, showing that high diagnostic performance did not translate into improved downstream care. Instead, the dominant failure modes reversed across phases. Explicit decision errors dominated anatomical staging at 48.2%, whereas decision omissions dominated initial work-up and post-treatment follow-up at 33.4% and 30.4%, respectively. In the evaluated model set, medically adapted models showed higher omission rates than general-purpose models. Moreover, varying query granularity exposes a critical specification trade-off: broad open-ended requests degrade Decision Quality across all 30 models, while more detailed, checklist-like prompts raise Decision Quality but reduce Evidence Faithfulness and Safety Adherence. Furthermore, NPC-RubricBench demonstrates that static diagnostic benchmarks are insufficient to ensure consistent clinical reliability over time, highlighting the importance of phase-adaptive safeguards in multistage medical AI.

0.47

CACSurv: Concordance-Aligned Comparative Learning with Large Language Models for Cancer Survival Prediction

cs.AI ·2026-08-17 ·Tianqi Xiang, Qixiang Zhang, Xinpeng Ding, Yi Li, Xiaomeng Li
benchmarkcode/data similarity 0.62
Abstract

Cancer survival prediction supports treatment planning, risk stratification, and follow-up management. Existing methods use structured clinical variables, whole-slide images, genomic profiles, or multimodal inputs, while patient reports remain underexplored. We study report-centric survival prediction using reports that organize pathological, clinical, and molecular evidence. Large language models (LLMs) can reason over such reports, but case-wise time regression introduces two mismatches. First, a formulation mismatch arises because survival evaluation depends on ordering comparable patients, whereas independent time predictions do not enforce ranking consistency. Second, a supervision mismatch arises because a censored patient's observed time indicates survival beyond that point and cannot serve as an exact regression target, although it still implies orderings relative to patients who died earlier. To address these mismatches, we propose CACSurv, a Concordance-Aligned Comparative framework for report-centric survival prediction. CACSurv reformulates survival modeling as mini-cohort comparative reasoning, where an LLM predicts relative prognostic orderings. We introduce concordance-aligned rewards derived from comparable relations under right censoring, enabling censored outcomes to provide ranking supervision without exact event-time targets. At inference, Monte Carlo Reference Aggregation compares each patient with sampled references and aggregates positions into a cohort-level ranking. We establish TCGA-SurvReport, a benchmark covering six TCGA cancer cohorts. CACSurv achieves the highest C-index on all six cohorts and an average C-index of 0.722, outperforming the strongest published survival model by 6.5 percentage points and the strongest LLM time-regression baseline by 4.2 percentage points. Our code, models, and dataset will be available at https://github.com/xmed-lab/CACSurv.

0.52

Scaling large language model-assisted line-of-therapy adjudication with human-in-the-loop evidence-calibrated selection

cs.LG q-bio.QMstat.AP ·2026-11-15 ·Olatunji Oni, Sanhita Sengupta, Marc De Benedetti, Nathanial Eddy
similarity 0.61
Abstract · 12 pages, 4 figures

Large language models (LLMs) have enabled the ability to scale clinical adjudication tasks traditionally dependent on exhaustive manual review. Line-of-therapy (LoT) adjudication, a major bottleneck in oncology cohort construction, is a prime example. Line boundaries must be inferred from longitudinal treatment histories according to nuanced, study-specific definitions, at every regimen transition for every patient. LLMs can apply this adjudication at scale, but their reliability varies across patients. Treatment histories differ in complexity, and ambiguous or atypical patterns depend on expert clinical judgment. Reliable automation thus requires verified support for model assignments and the ability to identify cases that warrant manual review. Here, we present evidence-calibrated selection (ECS), a human-in-the-loop framework for scaling LLM-assisted LoT adjudication. ECS derives confidence from observed clinician adjudications, prioritizes patients with the least-supported assignments for follow-up review, and returns completed adjudications to the model as precedent. As the evidence base grows, ECS continuously calibrates confidence to estimate residual error, thus enabling more efficient use of clinician time. In simulations on 136 clinician adjudicated patients with multiple myeloma, ECS achieved a residual error of 5% after review of 44.6% of patients, compared to 62.2% when review was directed by LLM self-reported confidence and 81.9% under random sampling. These results support a scalable approach to study-specific LoT adjudication, using clinician evidence to inform automated predictions, minimize error, and reduce review burden.

0.21

Prognosis Without Prediction: The Intrinsic Geometry of Survival

cs.LG q-bio.QM ·2026-11-18 ·Atahan Karagoz
code/data similarity 0.61
Abstract · Code available at: https://github.com/Atahanka/SOSM

Modeling systemic failure in high-dimensional environments is fundamentally limited by supervised algorithms that attempt to predict sparse, noisy or censored endpoints. To break this reliance on explicit outcome regression, we engineered the Self-Organizing Survival Manifolds (SOSM) framework, a deep learning architecture that decouples unsupervised representation learning from survival labels and treats time-to-event progression as an emergent geometric property. The system projects heterogeneous multi-omics arrays into a unified latent space governed by a pseudotime-weighted, curvature-minimizing graph Laplacian, organizing patient trajectories along low-dissipation geodesic flows. To validate the framework, we applied this architecture to a 184-patient clear cell renal cell carcinoma multi-omics cohort. Across a deterministic 5-fold cross-validation pipeline, SOSM achieved a mean Concordance Index of $0.768 \pm 0.068$, while out-of-fold risk stratification yielded significant survival divergence (log-rank $p < 0.001$) accompanied by a 14.7% increase in local manifold dissipation among high-risk patients. Furthermore, interrogating the network's encoder weights confirmed that the model autonomously recovered canonical metabolic and microenvironmental drivers of disease progression without supervised feature selection. By demonstrating that systemic failure can be mapped as a geometric phase transition, SOSM establishes a generalizable computational engine for prognostic modeling across biological, industrial and financial complex systems.

0.28

Saga: an in silico ontology for a multimodal patient world model

cs.CV ·2026-10-19 ·Youcheng Li, Fa Tian, Binbin Su
similarity 0.60
Abstract · 22 pages, 6 figures, 4 tables

Simulating an individual's disease course requires connecting patient history to future events, clinical timing and disease morphology. Longitudinal prediction and multimodal representations exploit this information, but organizing future readouts around a common patient state and advancing trajectories without real intermediate observations remain central challenges. Here we introduce Saga, a multimodal patient world model that learns a shared state from patient histories to predict clinical events and generate multimodal images. Generated events and times are appended to the history and re-encoded to advance prediction. We studied 461,370 patients with 12 cancer types across 112 centres. Modality-specific paired evaluations linked future images to observed follow-up. With historical images held fixed, removing patient conditioning reduced event F1 from 0.716 to 0.591 and increased lesion-burden error from 11.8% to 21.3%. In free rollouts, eight-step event F1 was 0.672, compared with 0.553 for a longitudinal Transformer evaluated from the same origins, and timing error was lower by 8.7 days. In the internal test set, one-year progression AUROC was 0.882, with values of 0.871 and 0.856 in temporal and geographical external evaluations. These results show that shared patient states connect future phenotypes across observational scales with event-driven trajectory progression, sustaining comparative predictive advantages during rollout and discrimination in external clinical evaluation. Saga makes patient-level disease simulation a multimodal prediction task that can be tested against observed follow-up.

0.21